Order Article Reprints

Basta G, Babboni S, Pezzati D, Del Turco S, Balzano E, Catalano G, Russo L, Tincani G, Carrai P, Petruccelli S, et al. Perfusate Liver Arginase 1 Levels After End-Ischemic Machine Perfusion Are Associated with Early Allograft Dysfunction. Biomedicines. 2025; 13(1):244. https://doi.org/10.3390/biomedicines13010244

Basta, Giuseppina, Serena Babboni, Daniele Pezzati, Serena Del Turco, Emanuele Balzano, Gabriele Catalano, Lara Russo, Giovanni Tincani, Paola Carrai, Stefania Petruccelli, and et al. 2025. "Perfusate Liver Arginase 1 Levels After End-Ischemic Machine Perfusion Are Associated with Early Allograft Dysfunction" Biomedicines 13, no. 1: 244. https://doi.org/10.3390/biomedicines13010244

Basta, G., Babboni, S., Pezzati, D., Del Turco, S., Balzano, E., Catalano, G., Russo, L., Tincani, G., Carrai, P., Petruccelli, S., Bronzoni, J., Martinelli, C., Palladino, S., Trizzino, A., Petagna, L., Romagnoli, R., Patrono, D., Biancofiore, G., Peris, A., ... Ghinolfi, D. (2025). Perfusate Liver Arginase 1 Levels After End-Ischemic Machine Perfusion Are Associated with Early Allograft Dysfunction. Biomedicines, 13(1), 244. https://doi.org/10.3390/biomedicines13010244